Tecan Group AG
SIX:TECN

Watchlist Manager
Tecan Group AG Logo
Tecan Group AG
SIX:TECN
Watchlist
Price: 116.6 CHF -0.93% Market Closed
Market Cap: CHf1.5B

Tecan Group AG
Cash Interest Paid

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Tecan Group AG
Cash Interest Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Interest Paid CAGR 3Y CAGR 5Y CAGR 10Y
Tecan Group AG
SIX:TECN
Cash Interest Paid
CHf2.4m
CAGR 3-Years
42%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Bachem Holding AG
SIX:BANB
Cash Interest Paid
CHf396k
CAGR 3-Years
75%
CAGR 5-Years
-1%
CAGR 10-Years
11%
Siegfried Holding AG
SIX:SFZN
Cash Interest Paid
CHf6.3m
CAGR 3-Years
-7%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Lonza Group AG
SIX:LONN
Cash Interest Paid
CHf164m
CAGR 3-Years
37%
CAGR 5-Years
27%
CAGR 10-Years
11%
PolyPeptide Group AG
SIX:PPGN
Cash Interest Paid
€9.1m
CAGR 3-Years
54%
CAGR 5-Years
55%
CAGR 10-Years
N/A
SKAN Group AG
SIX:SKAN
Cash Interest Paid
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Tecan Group AG
Glance View

Nestled in the heart of Switzerland lies Tecan Group AG, a company that has been quietly revolutionizing the laboratory world. Founded in 1980, Tecan has transformed itself from a small enterprise into a powerhouse in the life sciences and diagnostics sectors. The company's journey is one of precision and innovation, as it specializes in the development, production, and distribution of sophisticated laboratory instruments and solutions. These solutions are not merely products; they are the linchpins of automation that help streamline research, diagnostics, and the pharmaceutical sectors. Tecan's knack for integrating complex biochemical processes into accessible technology has proven critical for laboratories seeking speed and accuracy in processes like sample handling, testing, and data management. Tecan's business model thrives on a multifaceted approach. It sells its high-tech instruments and consumables directly to a diverse client base, including pharmaceutical companies, biotechnology firms, and research institutions. Beyond selling physical products, Tecan also benefits from providing value-added services such as after-sales support and bespoke system adaptations, ensuring that its clients can optimize their workflows. By combining cutting-edge technology with customer-centric service offerings, Tecan ensures recurring revenue streams. Its strategic prowess in securing long-term partnerships with leading institutions further cements its stance as not just a vendor, but a reliable partner in scientific discovery and healthcare advancement.

TECN Intrinsic Value
156.79 CHF
Undervaluation 26%
Intrinsic Value
Price CHf116.6

See Also

What is Tecan Group AG's Cash Interest Paid?
Cash Interest Paid
2.4m CHF

Based on the financial report for Dec 31, 2025, Tecan Group AG's Cash Interest Paid amounts to 2.4m CHF.

What is Tecan Group AG's Cash Interest Paid growth rate?
Cash Interest Paid CAGR 5Y
20%

Over the last year, the Cash Interest Paid growth was -2%. The average annual Cash Interest Paid growth rates for Tecan Group AG have been 42% over the past three years , 20% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett